BridgeBio Pharma: Barclays cuts target price to $156 from $157
BBIO•Barclays cut its target price for BridgeBio Pharma to $156 from $157.
Related News
Yorkville Ives initiates coverage of Zscaler with outperform rating and $250 target
ZS•
Innodata gets Outperform rating from Yorkville Ives with $90 target
INOD•
Penguin Solutions Inc: Stifel raises target price to $85 from $75
PENG•
Zoom Communications: Yorkville Ives initiates coverage with outperform rating; target price $120
ZM•
Apple Inc.: Yorkville Ives initiates coverage with outperform rating; target price $400.00
AAPL•